| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-11 | Capital World Investors | GW PHARMACEUTICALS PLC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-03-10 | Capital Research Global Investors | GW PHARMACEUTICALS PLC | 16,701,517 | 4.5% | EDGAR |
| SC 13G/A | 2021-02-16 | Capital Research Global Investors | GW PHARMACEUTICALS PLC | 44,834,512 | 12.0% | EDGAR |
| SC 13G | 2021-02-16 | Capital World Investors | GW PHARMACEUTICALS PLC | 33,084,159 | 8.8% | EDGAR |
| SC 13G | 2021-02-12 | JANUS HENDERSON GROUP PLC | GW PHARMACEUTICALS PLC | 1,975,301 | 6.5% | EDGAR |
| SC 13G/A | 2021-02-01 | FRANKLIN RESOURCES INC | GW PHARMACEUTICALS PLC | 23,080,308 | 6.2% | EDGAR |
| SC 13G/A | 2020-02-14 | Capital Research Global Investors | GW PHARMACEUTICALS PLC | 43,476,806 | 11.7% | EDGAR |
| SC 13G/A | 2020-02-14 | Capital World Investors | GW PHARMACEUTICALS PLC | 13,255,261 | 3.5% | EDGAR |
| SC 13G/A | 2020-02-12 | MORGAN STANLEY | GW PHARMACEUTICALS PLC | 14,385,918 | 3.9% | EDGAR |
| SC 13G | 2020-02-04 | FRANKLIN RESOURCES INC | GW PHARMACEUTICALS PLC | 27,516,372 | 7.4% | EDGAR |
| SC 13G | 2019-12-09 | MORGAN STANLEY | GW PHARMACEUTICALS PLC | 18,904,590 | 5.1% | EDGAR |
| SC 13G/A | 2019-02-14 | SMALLCAP WORLD FUND INC | GW PHARMACEUTICALS PLC | 28,955,761 | 7.9% | EDGAR |
| SC 13G/A | 2019-02-14 | SCOPIA CAPITAL MANAGEMENT LP | GW PHARMACEUTICALS PLC | 1,345,198 | 4.6% | EDGAR |
| SC 13G/A | 2019-02-14 | Capital Research Global Investors | GW PHARMACEUTICALS PLC | 43,286,018 | 12.0% | EDGAR |
| SC 13G/A | 2019-02-14 | Capital World Investors | GW PHARMACEUTICALS PLC | 32,538,865 | 9.0% | EDGAR |
| SC 13G | 2019-02-14 | EUROPACIFIC GROWTH FUND | GW PHARMACEUTICALS PLC | 21,797,989 | 6.0% | EDGAR |
| SC 13G/A | 2018-06-11 | SCOPIA CAPITAL MANAGEMENT LP | GW PHARMACEUTICALS PLC | 1,929,767 | 6.8% | EDGAR |
| SC 13G/A | 2018-02-14 | SMALLCAP WORLD FUND INC | GW PHARMACEUTICALS PLC | 26,247,505 | 7.8% | EDGAR |
| SC 13G/A | 2018-02-14 | SCOPIA CAPITAL MANAGEMENT LP | GW PHARMACEUTICALS PLC | 3,455,054 | 12.2% | EDGAR |
| SC 13G/A | 2018-02-14 | M&G INVESTMENT MANAGEMENT LTD | GW PHARMACEUTICALS PLC | 20,800,044 | 6.9% | EDGAR |